Filing summary
Entity and period: The request metadata names AIRWA Inc., but the filing identifies the registrant as Connexa Sports Technologies Inc. (Nasdaq: CNXA). This unaudited Form 10-Q covers the quarter and six months ended October 31, 2023, in the company’s fiscal year ending April 30, 2024.
Business context and financial performance
Connexa sells sports equipment, including the Slinger portable ball launcher, and sports technology through Gameface AI. PlaySight and most of Foundation Sports were sold in 2022 and are treated as discontinued operations in the comparative period.
| Metric | Three months ended Oct. 31, 2023 | Six months ended Oct. 31, 2023 | Comparable 2022 period |
|---|---|---|---|
| Net sales | $2.30 million | $5.42 million | $2.44 million quarter; $6.03 million six months |
| Gross profit / margin | $646,963 / approximately 28.2% | $1.54 million / approximately 28.4% | $287,041 / approximately 11.7% quarter; $1.31 million / approximately 21.7% six months |
| Operating loss | $1.27 million | $3.13 million | $4.51 million quarter; $7.58 million six months |
| Reported net income (loss) | $1.76 million | $915,354 | Loss of $11.02 million quarter; $15.29 million six months, before discontinued-operation losses |
| Operating cash flow | Not presented separately for the quarter | Cash used: $648,056 | Cash used: $5.999 million in the six-month cash flow statement |
Revenue fell 6% for the quarter and 10% for the six months. Management attributed the decline to inventory depletion after higher-than-planned orders; it cited $207,700 of orders received but not invoiced in the quarter. Gross margin improved as shipping, container and import-duty costs declined. Operating expenses also fell substantially, partly because of lower staffing, legal and share-based compensation costs. Research and development spending was zero; management said development was paused because cash was limited.
Reported net income is not a clear measure of underlying operating performance: it included noncash gains from changes in derivative fair value of $14.8 million for the quarter and $16.9 million for the six months, alongside derivative expense of $11.4 million in each period. The filing’s EPS note adjusts for the derivative fair-value gain and reports adjusted losses per share of $14.29 for the quarter and $23.13 for the six months. The filing does not provide a conventional adjusted net-income measure.
Liquidity, debt and capital structure
- At October 31, cash was $285,861, current assets were $3.46 million and current liabilities were $18.46 million; the resulting working-capital deficit was approximately $15.0 million. Total liabilities were $19.86 million, compared with total assets of $5.46 million. Stockholders’ deficit was $14.40 million.
- Cash increased by $83,766 from April 30. Six-month operating cash use of $648,056 was offset by $654,479 of financing cash flow, including $1.276 million of note proceeds and repayments. The company reported no investing cash flow.
- Current notes payable, net, were $3.19 million; long-term related-party notes were $1.40 million. Accrued related-party interest was $917,957. These amounts sit alongside substantial trade payables and accrued expenses.
- The company used merchant cash advances secured by receivables, with weekly remittances. An October 2023 amended institutional loan increased the facility to $3.0 million, due April 11, 2024, and included warrants. A subsequent November 2023 receivables-financing agreement provided $450,000 in cash against $693,500 of receivables, repayable at $28,895.83 per week.
- Shares issued and outstanding increased from 338,579 at April 30 to 2,372,803 at October 31. The cover reports 3,436,174 shares outstanding on November 24, after additional share issuances and warrant exercises.
Outlook, risks and unusual items
- Going concern: Management states that substantial doubt exists about the company’s ability to continue as a going concern, citing its accumulated deficit of $150.8 million, expected further losses and dependence on financing or profitable operations. It plans to use existing cash, related-party loans and/or private placements; it says spending or development may be reduced or delayed if financing or revenue is insufficient. No quantified revenue or earnings guidance is provided.
- Nasdaq listing: Nasdaq gave the company until January 22, 2024 to demonstrate compliance with the $2.5 million minimum stockholders’ equity requirement. The company warns there is no assurance it will regain or maintain compliance.
- Israel-related exposure: The company develops products in Israel and disclosed risks from the Israel-Hamas war, including possible staff or supplier disruption, business interruption, trade restrictions and damage not covered by commercial insurance.
- Controls: Management concluded internal control over financial reporting was not effective at October 31. Disclosed material weaknesses include inadequate segregation of duties and oversight, limited accounting resources, and inventory-processing and reconciliation controls that contributed to audit adjustments. Remediation was still in progress.
- Legal matter: Oasis Capital filed an amended lawsuit against the company and its CEO alleging fiduciary-duty and securities-law violations and seeking unspecified damages. The company says it considers the claims without merit and is defending the case.
- Other items: The company impaired $100,281 of intangible assets and $14,791 of fixed assets during the six months. It holds a $2.0 million note receivable from former subsidiary PlaySight, with a stated maturity of December 31, 2023 and contractual provisions that may extend or otherwise settle the obligation. Customer and supplier concentration is significant: two customers represented 77% of receivables and four suppliers 69% of payables at October 31.
The filing’s MD&A contains some inconsistent figures: quarterly gross profit is stated as both $646,963 and $646,943, and its discussion of prior-year operating cash flow does not match the cash flow statement. Figures above generally use the financial statements; investors should verify these discrepancies in the filing.
Important facts for investors to verify
- Confirm the correct issuer: the supplied metadata says AIRWA Inc., while the filing is for Connexa Sports Technologies Inc. (CNXA).
- Review the cash runway, weekly merchant-finance obligations, loan maturity and availability of further financing, given the going-concern warning and low cash balance.
- Track Nasdaq compliance progress and the effect of further warrant exercises, share issuances and reverse stock splits on dilution and listing status.
- Assess whether sales can recover from inventory constraints and whether paused product development affects future demand or competitiveness.
- Verify the derivative-related accounting gains and expenses, the stated EPS adjustments, the PlaySight note’s collection or settlement, and the status and potential exposure of the Oasis litigation.
- Monitor remediation of material weaknesses and any effects of the Israel conflict on employees, suppliers, product development and deliveries.